Serum C-reactive Protein Level and Its Correlation with Metabolic Syndrome

Authors
Hassan Mehrad Majd
Mahdieh Bayat
Majid Ghayour Mobarhan
Mohsen Aziminezhad
Abasalt Borji
Abstract
Introduction and Aims

A growing body of evidence indicates the role of inflammation and inflammatory indicators such as Cytokines and other inflammatory mediators as triggering factors in the development of metabolic syndrome (MetS) and other metabolic disorders. This study was designed to investigate the possible association between high sensitivity C reactive proteins (hs-CRP) with components of metabolic syndrome.

Materials and Methods

In this case control study a total of 421 individuals including 215 patients with metabolic syndrome and 206 healthy controls were selected randomly from Mashhad as a second largest city in Iran. MetS was defined based on Adult Treatment Panel III criteria. Anthropometric variables such as weight, body mass index, waist circumference, hip circumference, waist-to-hip ratio, systolic and diastolic blood pressure as well as biochemical profiles and inflammatory marker (hs-CRP) were measured by standard methods.

Results

The mean values of anthropometric and clinical variables, including FBS, TG and total cholesterol, were significantly higher in MetS group compared with controls (P<0.05), while HDL was significantly higher in the control group (P<0.05). There were no significant differences in the distribution of gender and age between controls and patients with MetS. In subjects with the MetS, hs-CRP concentration was higher than those in controls (P<0.05). There was also a significant correlation between the concentration of hs-CRP and serum triglyceride levels in men with MetS and serum HDL- cholesterol levels in women of the control group.

Conclusion

hs-CRP concentration increased in patients with MetS and was positively associated with TG levels in men and HDLcholesterol in healthy women.



* Corresponding Author: Mashhad University of Medical Sciences, Clinical Research Development Unit.

Email: Mehradmajd.h@gmail.com
Keywords
metabolic syndrome
C reactive protein
inflammatory marker
Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2010;375(9710):181-3.

Azimi-Nezhad M, Herbeth B, Siest G, Dadé S, Ndiaye NC, Esmaily H, et al. High prevalence of metabolic syndrome in Iran in comparison with France: what are the components that explain this?. Metab Syndr Relat Disord. 2012;10(3):181-8.

Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005;111(11):1448-54.

Cuda C. The role of inflammation in metabolic syndrome. Studies by Undergraduate Researchers at Guelph, 2008;1(2):82-90.

Esposito K, Giugliano D. The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis. 2004;14(5):228-32.

Farooq W, Farwa U, Khan FR. The metabolic syndrome and inflammation: role of insulin resistance and increased adiposity. Oman Med J. 2015;30(2):100-3.

Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep. 2005;5(1):70-5.

Yudkin JS, Juhan-Vague I, Hawe E, Humphries SE, di Minno G, Margaglione M, et al. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism. 2004;53(7):852-7.

Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15(11):2792-800.

Huffman FG, Gomez GP, Zarini GG. Metabolic syndrome and high-sensitivity C-reactive protein in Cubans. Ethn Dis. 2009;19(2):115-20.

Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102(18):2165-8.

Timpson NJ, Lawlor DA, Harbord RM, Gaunt TR, Day IN, Palmer LJ, et al. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet. 2005;366(9501):1954-9.

Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. 2007;49(21):2129-38.

Erren M, Reinecke H, Junker R, Fobker M, Schulte H, Schurek JO, et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol. 1999;19(10):2355-63.

Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem. 2001;47(3):403-11.

Jung CH, Lee WY, Kim BY, Park SE, Rhee EJ, Park CY, et al. The risk of metabolic syndrome according to the high-sensitivity C-reactive protein in apparently healthy Koreans. Int J Cardiol. 2008;129(2):266-71.

Hosseinpour-Niazi S, Alamdari S, Mirmiran P, Hoseeini-Esfahani F, Azizi F. Inflammatory Markers, the Metabolic Syndrome and Body Mass Index in Adults. Iran J Endocrin Metabol. 2013;15(3):237-43. [Persian]

Maleki A, Rashidi N, Aghaei Meybodi H, Montazeri M, Montazeri M, Falsafi F, et al. Metabolic syndrome and inflammatory biomarkers in adults: a population-based survey in Western region of iran. Int Cardiovasc Res J. 2014;8(4):156-60.

Zuliani G, Volpato S, Galvani M, Ble A, Bandinelli S, Corsi AM, et al. Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study. Atherosclerosis. 2009;203(2):626-32.

Tamakoshi K, Yatsuya H, Kondo T, Hori Y, Ishikawa M, Zhang H, et al. The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord. 2003;27(4):443-9.

Foroughi M, Hosseinzadeh M, Zahediasl S, Hoseinpanah F, Momenan A, Eshraghiyan M, et al. Serum Visfatin Concentration in Patients with Metabolic Syndrome. Iran J Endocrinol Metab. 2009;11(2):151-7. [Persian]

Zarkesh M, Faam B, Daneshpour M, Azizi F, Hedayati M. [Association of serum C-reactive protein, homocysteine and interleukin-6 with metabolic syndrome]. Iran J Diabet Lipid Disord. 2013;12(6):564-73. [Persian]

da Cruz LL, Cardoso LD, Pala D, de Paula H, Lamounier JA, Silva CA, et al. Metabolic syndrome components can predict C reactive protein concentration in adolescents. Nutr Hosp. 2013;28(5):1580-6.

Bremer AA, Jialal I. Adipose tissue dysfunction in nascent metabolic syndrome. J Obes. 2013;2013:393192.